Indication
Posttraumatic
2 clinical trials
2 products
1 drug
Clinical trial
Suvorexant: A Dual Orexin Receptor Antagonist for Treating Sleep Disturbance inPosttraumatic StressStatus: Recruiting, Estimated PCD: 2024-12-31
Product
SuvorexantClinical trial
Prazosin Augmentation of Outpatient Treatment of Alcohol Use Disorders in Active Duty Soldiers With and Without PTSDStatus: Completed, Estimated PCD: 2018-09-20
Product
PrazosinDrug
placebo